Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
Author:
Affiliation:
1. Experimental Therapeutics and Pathophysiology Branch, NIMH-NIH, Bethesda, Maryland, USA
2. Laboratory of Neuroscience, LIM- 27, Institute and Department of Psychiatry, University of São Paulo, São Paulo, Brazil
Funder
National Institute of Mental Health
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2017.1253472
Reference121 articles.
1. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
3. Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
4. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
5. Rapid Onset of Antidepressant Action
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery;International Journal of Molecular Sciences;2023-02-02
2. Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2022-05-23
3. Influence of aging on chronic unpredictable mild stress-induced depression-like behavior in male C57BL/6J mice;Behavioural Brain Research;2021-09
4. Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression;Current Medicinal Chemistry;2021-08-02
5. Exploring real-world evidence to uncover unknown drug benefits and support the discovery of new treatment targets for depressive and bipolar disorders;Journal of Affective Disorders;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3